Search

Your search keyword '"Endo, Hironobu"' showing total 188 results

Search Constraints

Start Over You searched for: Author "Endo, Hironobu" Remove constraint Author: "Endo, Hironobu"
188 results on '"Endo, Hironobu"'

Search Results

1. Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder

2. A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease

4. Association of protein distribution and gene expression revealed by positron emission tomography and postmortem gene expression in the dopaminergic system of the human brain

5. Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases

6. Investigating neural dysfunction with abnormal protein deposition in Alzheimer’s disease through magnetic resonance spectroscopic imaging, plasma biomarkers, and positron emission tomography

7. Two pathways differentially linking tau depositions, oxidative stress, and neuronal loss to apathetic phenotypes in progressive supranuclear palsy

9. An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607)

10. PET-based classification of corticobasal syndrome

11. In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy

12. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

13. In vivo PET classification of tau pathologies in patients with frontotemporal dementia

15. Development and Comparison of a Novel Mid‐Region Directed p‐Tau 181 Assay with Tau Positron Emission Tomography in Alzheimer’s Disease

16. In vivo characterization of tau accumulation in patients with frontotemporal dementia: A PET study with 18F‐florzolotau

17. The aftermath of boxing: Longitudinal changes of cerebral retention patterns of 18F‐florzolotau (18F‐APN‐1607) in the former professional boxers

18. Involvement of differential tau pathologies in late‐onset bipolar disorder assessed by PET with 18F‐florzolotau

19. In vivoassessment of astrocyte reactivity in patients with progressive supranuclear palsy

21. Development and Performance Assessment of a Novel Plasma p-Tau181 Assay Reflecting Tau Tangle Pathology in Alzheimer's Disease

22. Altered brain energy metabolism related to astrocytes in Alzheimer's disease

25. Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease.

27. Correlation of 18F-PM-PBB3 (18F-florzolotau) Tau PET Imaging with Postmortem Neuropathological Findings in A Case with Progressive Supranuclear Palsy (P9-11.015)

28. Investigating Neural Dysfunction with Abnormal Protein Deposition in Alzheimer’s Disease Through Magnetic Resonance Spectroscopic Imaging, Plasma Biomarkers, and Positron Emission Tomography

30. Case report: Saccadic ping-pong gaze in progressive supranuclear palsy with predominant postural instability

32. Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study With 11C-WAY-100635 and 18F-MPPF.

35. High‐Contrast Imaging of α‐Synuclein Pathologies in Living Patients with Multiple System Atrophy

36. A Machine Learning–Based Approach to Discrimination of Tauopathies Using [18 F] PM‐PBB3 PET Images

37. Altered brain energy metabolism related to astrocytes in tauopathies.

38. Involvement of differential tau pathologies in late‐onset bipolar disorder assessed by PET with 18F‐florzolotau.

39. The aftermath of boxing: Longitudinal changes of cerebral retention patterns of 18F‐florzolotau (18F‐APN‐1607) in the former professional boxers.

40. An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with 18F-PM-PBB3 (18F-APN-1607)

41. First-in-human in vivo undefined imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401

42. Serotonergic Neurotransmission in Limbic Regions May Reflect Therapeutic Response of Depressive Patients: A PET Study with 11C-WAY-100635 and 18F-MPPF

43. First-In-Human in Vivo Imaging and Quantification of Monoacylglycerol Lipase in The Brain: A PET Study With 18F-T-401

44. In Vivo Binding of a Tau Imaging Probe, [11C]PBB3, in Patients With Progressive Supranuclear Palsy

45. A Machine Learning–Based Approach to Discrimination of Tauopathies Using [18F]PM‐PBB3 PET Images.

47. First-in-human in vivo imaging and quantification of monoacylglycerol lipase in the brain: a PET study with 18F-T-401.

48. Associations of the tau protein and oxidative stress to apathy levels in patients with progressive supranuclear palsy

49. Tau imaging detects distinctive distribution of tau pathology in ALS/PDC on the Kii Peninsula

50. Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease

Catalog

Books, media, physical & digital resources